Lv11
45 积分 2026-04-09 加入
Disparities in Outcomes of Cutaneous T-Cell Lymphoma in US Patients Aged < 40 Years Compared to Older Population
2小时前
求助中
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
1个月前
已完结
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification
5个月前
已完结
皖公网安备34019202002308
